ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Contact
✕
March 23, 2023
Person walking on directional sign
March 23, 2023
Categories
  • Editorials

Should I stay or should I go?

Many patients are unaware that stopping treatment during participation in a clinical trial does not automatically mean withdrawing from a clinical trial
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • New Trials

The ComboMATCH precision medicine initiative is getting set to evaluate several new anti-cancer drug combinations

Hospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • Ongoing Trials

Video: Advocates discuss the EA2185 research study for patients with pancreatic cysts

Watch cancer research advocates Lisa Beckendorf and Steven Merlin discuss the EA2185 study for patients with pancreatic cysts
Do you like it?
0 Read more
March 23, 2023
Doctor talking with older male patient
March 23, 2023
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s myeloma studies

These two trials are exploring new treatment approaches for adults with multiple myeloma
Do you like it?
0 Read more
12
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Tags

Acute lymphoblastic leukemia Adolescents and young adults Advocacy Bladder cancer Breast cancer Caregiving Communication De-escalation Head and neck cancer Health equity HER2+ breast cancer Immune system therapy Immunotherapy In memory Kidney cancer Leukemia Lung cancer Lymphoma Mammography Mantle cell lymphoma Melanoma Multiple myeloma Myeloma NCI-MATCH Nose and sinus cancer Pancreatic cancer Pancreatic cysts Patient care Personalized medicine Personalized screening Personalized treatment Precision medicine Prevention Prostate cancer Renal cell carcinoma Research results Sarcoma Screening Side effects Squamous cell carcinoma Surveillance Survivorship Symptom management Targeted therapy Throat cancer

Archives

  • July 2025
  • May 2025
  • January 2025
  • September 2024
  • July 2024
  • March 2024
  • January 2024
  • October 2023
  • July 2023
  • March 2023
  • January 2023
  • September 2022
  • June 2022
  • March 2022
  • December 2021
  • September 2021
  • June 2021
  • March 2021
  • October 2020
  • June 2020
  • February 2020
  • October 2019

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc